Meta-analyses of the literature point to peripheral blood levels of IL-6, TNF-α, and C-reactive protein (CRP) to be the most promising biomarkers of inflammation in adult MDD patients [50–53]. The gene discussed is CRP; the disease is major depressive disorder.